Lifestyle advice follow-up improve glycemic control, redox and inflammatory status in patients with type 2 diabetes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007, 334: 1–9. 10.1136/bmj.39063.689375.55
American Diabetes Association: Diagnosis and classification of diabetes mellitus Diabetes Care 2008, 31(1):S55-S60. 10.2337/dc08-S055
Mann JI: Nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome: an evidenced-based review. Nutr Rev 2006, 64: 422–427. 10.1111/j.1753-4887.2006.tb00227.x
Zander E, Kerner W: Cardiovascular risk factors in type 1 and type 2 diabetes: common conventional and diabetes-related risk variables? In Vascular Involvement in Diabetes: Clinical, Experimental and Beyond. Edited by: Cheta D. Karger, Basel; 2005. 1: 264–271
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141: 421–431. 10.7326/0003-4819-141-6-200409210-00007
Institut National de Santé Publique 2009: Enquête diabète. Ministère de la santé, de la population et de la réforme hospitalière, Alger. Étude de l’épidémiologie du diabète de type 2 dans des populations endogames de l’ouest Leban Sci J 2012, 13(2):17–26.
Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, Portero-Otin M: Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009, 11(12):3071–3109. 10.1089/ars.2009.2484
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44–84. 10.1016/j.biocel.2006.07.001
Sekeroglu MR, Sahin H, Dulger H, Algun E: The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem 2000, 33: 669–674. 10.1016/S0009-9120(00)00190-9
Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress and antioxidants. A review. J Biochem Mol Toxicol 2003, 17: 24–38. 10.1002/jbt.10058
Goyal R, Faizy AF, Siddiqui SS, Singhai M: Evaluation of TNF-α and IL-6 levels in obese and non-obese diabetics: pre and post-insulin effects. North Am J Med Sci 2012, 4(4):180–184. 10.4103/1947-2714.94944
Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003, 149: 331–335. 10.1530/eje.0.1490331
Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, Fukui M, Yoshikawa T, Nakamura N: Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 2005, 42: 104–109. 10.1007/s00592-005-0187-x
Laudes M, Oberhauser F, Schulte DM, Freude S, Bilkovski R, Mauer J, Rappl G, Abken H, Hahn M, Schulz O, Krone W: Visfatin/PBEF/Namptand resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans. Horm Metab Res 2010, 42: 268–273. 10.1055/s-0029-1243638
Abdin AA, Baalash AA, Hamooda HE: Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. J Diabetes Complicat 2010, 24: 168–178. 10.1016/j.jdiacomp.2009.01.005
Quintanilha AT, Packer L, Szyszlo JM, Racanelly TL, Davies KJ: Membrane effects of vitamin E deficiency bioenergetic and surface charge density studies of skeletal muscle and liver mitochondria. Ann NY Acad Sci 1982, 393: 32–47. 10.1111/j.1749-6632.1982.tb31230.x
Eymard S, Genot C: A modified xylenol orange method to evaluate formation of lipid hydroperoxides during storage and processing of small pelagic fish. Eur J Lipid Sci Technol 2003, 105: 497–501. 10.1002/ejlt.200300768
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186: 464–478. 10.1016/0076-6879(90)86141-H
Cortas N, Wakid N: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990, 36: 1440–1443.
Aebi H: Catalase. In Methods of enzymatic analysis. 2nd edition. Edited by: Berg Meyer H. Verlag Chemie, Weinheim; 1974:673–684. 10.1016/B978-0-12-091302-2.50032-3
Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB: Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 2004, 159(12):1150–1159. 10.1093/aje/kwh167
Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB: Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005, 81(3):555–563.
Brinke RT, Dekker N, de Groot M, Ikkersheim D: Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality. Prim Care Diabetes 2008, 2: 45–49. 10.1016/j.pcd.2007.12.004
Duclos M, Gautier JF: Physical activity and type 2 diabetes mellitus. Méd Mal Métaboliques 2009, 3(1):31–38. 10.1016/S1957-2557(09)70101-4
Hegde SV, Adhikari PMN, D’Souza V: Effect of daily supplementation of fruits on oxidative stress indices and glycaemic status in type 2 diabetes mellitus. Complement Ther Clin Pract 2013, 19: 97–100. 10.1016/j.ctcp.2012.12.002
Chen HS, Jap TS, Chen RL, Lin HD: A prospective study of glycemic control during holiday time in type 2 diabetic patients. Diabetes Care 2004, 27(2):326–330. 10.2337/diacare.27.2.326
Richard D, Bausero P, Schneider C, Visioli F: Polyunsaturated fatty acids and cardiovascular disease. Cell Mol Life Sci 2009, 66(20):3277–3288. 10.1007/s00018-009-0085-4
Risérus U, Willett WC, Hu FB: Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009, 48(1):44–51. 10.1016/j.plipres.2008.10.002
Fidanza F, Alberti A, Lanti M, Menotti A: Mediterranean adequacy index correlation with 25-years mortality from coronary heart disease in the seven countries study. Nutr Metab Cardiovasc Dis 2004, 14: 254–258. 10.1016/S0939-4753(04)80052-8
Sacks FM: Dietary fat, the Mediterranean diet, and health: reports from scientific exchanges, 1998 and 2000. Introduction. Am J Med 2002, 113(9B):1–4. 10.1016/S0002-9343(01)00985-8
Tall AR: Exercise to reduce cardiovascular risk. How much is enough? N Engl J Med 2002, 347(19):1522–1524. 10.1056/NEJMe020117
Mehrotra S, Ling KL, Bekele Y, Gerbino E, Earle KA: Lipid hydroperoxide and markers of renal disease susceptibility in African–Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 2001, 18: 109–115. 10.1046/j.1464-5491.2001.00416.x
Savu O, Ionescu-Tirgoviste C, Atanasiu V, Gaman L, Papacocea R, Stoian I: Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Int Med Res 2012, 40(2):709–716. 10.1177/147323001204000235
Nourooz-Zadeh J, Tajaddini-Sarmandi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995, 44(9):1054–1058. 10.2337/diab.44.9.1054
Telai A, Cakatery U, Kayali R, Erdogan C, Orhan Y, Sivas A, Akçay T: Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 2000, 32: 40–43. 10.1055/s-2007-978584
Faure P, Troncy L, Lecomte M, Wiernsperger N, Lagarde M, Ruggiero D, Halimi S: Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Mediab 2005, 31: 169–177. 10.1016/S1262-3636(07)70183-0
Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P: Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006, 291: E906-E912. 10.1152/ajpendo.00002.2006
Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, MacAllister RJ: Inflammation induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004, 64: 172–178. 10.1016/j.cardiores.2004.06.020
Monastyrskaya E, Folarin N, Malyshev I, Green C, Andreeva L: Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 2002, 7: 127–131. 10.1016/S1089-8603(02)00107-6
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ: Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293: C584-C589. 10.1152/ajpcell.00600.2006
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114: 1752–1761. 10.1172/JCI21625
Bandeira SM, Guedes S, da Fonseca LJ, Pires AS, Gelain DP, Moreira JC, Rabelo LA, Vasconcelos SM, Goulart MO: Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxid Med Cell Longev 2012, 819310: 1–13. 10.1155/2012/819310
Blum J, Fridovich I: Inactivation of glutathione peroxidase by superoxide dismutase radical. Arch Biochem Biophys 1985, 240: 500–508. 10.1016/0003-9861(85)90056-6
Jain SK, Robert M: Effect of glycemic control, race (White vs Black), and duration of diabetes on reduced glutathione content in erythrocyte of diabetes patients. Metabolism 1994, 43(3):306–309. 10.1016/0026-0495(94)90097-3
Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G: A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003, 52(7):1611–1618. 10.2337/diabetes.52.7.1611
Festa A, D’Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 51(4):1131–1137. 10.2337/diabetes.51.4.1131
Brighenti F, Valtuena S, Pellegrini N, Ardigò D, Del Rio D, Salvatore S, Piatti P, Serafini M, Zavaroni I: Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 2005, 93(5):619–625. 10.1079/BJN20051400
Oliver E, Mc Gillicuddy F, Phillips C, Toomey S, Roche HM: Postgraduate Symposium. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Proc Nutr Soc 2010, 69(2):232–243. 10.1017/S0029665110000042